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Abstract
Background: Overweight and obesity are known to impact male fertility and are commonly associated with
abdominal obesity and metabolic disorders. The association between abdominal obesity or metabolic syndrome
with male reproduction has not been fully investigated. Moreover, many factors may interfere with the evaluation
of the impact of metabolic syndrome on male fertility. Thus, tobacco is known to alter the spermatic parameters
and phenomena linking smoking with metabolic syndrome are therefore complex. The main objective of this study
has been to investigate the potential association of metabolic syndrome with male idiopathic infertility given
smoking status.
Materiel and methods: The data of this study concerned infertile (n = 96) and fertile (n = 100) men under 45 years
of age who have been recruited in the ALIFERT case-control study. Body mass index and waist circumference were
measured. Serum triglycerides, cholesterol (total, high density lipoprotein, and low density lipoprotein cholesterol)
and fasting blood glucose were assayed. Metabolic syndrome has been diagnosed in the presence of at least three
of the following criteria: increased waist circumference, high triglycerides, fasting glucose or arterial blood pressure
and low high density lipoprotein cholesterol.
Results: The present study reports that infertile men are in poorer health condition compared to fertile men and
are more often smokers. The results of this study suggested metabolic syndrome and smoking to be independent
risk factor for idiopathic infertility.
Conclusions: Metabolic syndrome and smoking should systematically be checked at the beginning of medical care
in infertile males and personal and multifaceted coaching should be proposed to deal jointly with smoking and
metabolic disorders.
Trial registration: NCT01093378 ALIFERT. Registered: March 25, 2010.
Keywords: Metabolic syndrome, Male fertility, Smoking
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Résumé
Contexte général: Le surpoids et l’obésité sont connus pour avoir un impact sur la fertilité masculine et sont
souvent associés à l’obésité abdominale et aux désordres métaboliques. L’association entre l’obésité abdominale ou
le syndrome métabolique et les fonctions de reproduction masculine n’est. pas totalement élucidé. De plus, de
nombreux facteurs confondants peuvent interférer avec la fertilité masculine. Ainsi, le tabac est. connu pour altérer
les paramètres spermatiques et des mécanismes complexes lient le tabagisme au syndrome métabolique. L’objectif
principal de cette étude est. d’étudier l’association potentielle entre le syndrome métabolique et l’infertilité
idiopathique masculine, compte tenu du statut tabagique.
Matériel et méthodes: Les données de cette étude portent sur des hommes de moins de 45 ans infertiles (n = 96)
et fertiles (n = 100) qui ont été recrutés dans le cadre de l’étude cas-témoins ALIFERT. L’indice de masse corporelle
et le tour de taille ont été mesurés. Les triglycérides sériques, le cholestérol (total, high density lipoprotein, low
density lipoprotein) et la glycémie à jeun ont été analysés. Le syndrome métabolique a été diagnostiqué en
présence d’au moins trois des critères suivants: un tour de taille accru, des triglycérides élevés, une glycémie à jeun
ou une tension artérielle élevée et un faible taux de cholestérol « high density lipoprotein ».
Résultats: Cette étude rapporte que les hommes infertiles sont en moins bonne santé que les hommes fertiles et
sont plus souvent des fumeurs. Les résultats de cette étude suggèrent que le syndrome métabolique et le
tabagisme sont des facteurs de risque indépendants de l’infertilité idiopathique.
Conclusions: Le syndrome métabolique et le tabagisme devraient être systématiquement contrôlés au début des
soins médicaux chez les hommes infertiles et un accompagnement personnel et multidisciplinaire devrait être
proposé pour traiter conjointement le tabagisme et les troubles du métabolisme.
Mots clés: Syndrome métabolique, Fertilité masculine, Tabagisme
Introduction
The decline of sperm parameters has been noticed by
health care professionals for several years. A meta-analysis
has shown that sperm concentration decreased by 52.4%
between 1973 and 2011 [1]. It has been hypothesized that
this reduction could be associated with the environment
and various factors that affect lifestyle, such as exposure
to pollution, radiation, high temperatures, and environ-
mental toxicants. Endocrine disrupters in the air, in food,
in drinking water, and in cosmetics have also been associ-
ated with sperm quality alterations [2]. Furthermore, life-
style factors that may compromise male gamete
production include tobacco, inadequate diet, lack of phys-
ical activity, overweight, obesity, and metabolic syndrome
[3]. In particular, the association between changes in
sperm characteristics and lifestyle factors is of interest be-
cause of the reversibility of those factors and the possibil-
ity of acting upon them [4].
Overweight and obesity are documented health con-
cerns worldwide, and cohort studies have linked excess
body mass index (BMI) with infertility in both males and
females [5]. Several studies [6–8] and a meta-analysis [9]
have highlighted semen parameter alterations, especially
the decrease in sperm count in overweight and obese
subjects. An association between obesity and altered
sperm DNA integrity has also been suspected [10].
Given its association with fat accumulation, BMI has
commonly been used as a proxy to assess body corpulence,
but BMI has traditionally not allowed for the
discrimination between subcutaneous and visceral
fat. The location of body fat has also been shown to
be associated with the development of comorbidities
in obese individuals. Therefore, excess fat in specific
locations of the body might be a more accurate
marker of disease than overall BMI [11]. Abdominal
obesity is one component of the metabolic
syndrome. Metabolic syndrome is defined as the
combination of at least three factors including high
waist circumference, high triglycerides, high
glycaemia, high blood pressure, and low high-density
lipoprotein (HDL) cholesterol [12]. The association
between abdominal obesity or metabolic syndrome
and male reproduction has not been fully investi-
gated to date, but negative associations with repro-
ductive hormones and semen have been previously
suggested, although not proven [3, 13–15]. Some
studies have reported an impact of the metabolic
syndrome on sperm parameters or hormone balance
[16]. Nevertheless, there remains controversy [17],
which may partly be explained by the heterogeneity
of the phenotypes of the metabolic syndrome and its
different definitions.
Smoking has been demonstrated to have detrimental
effects on human health [18]. Besides cardiovascular and
carcinogenic effects, smoking also challenges both male
and female reproductive functions [19, 20]. In males,
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several studies and a meta-analysis have shown a
negative association of smoking with semen parameters
[21, 22], but less is known about a potential association
with male fertility [23].
Although weight gain after smoking cessation has also
been reported [24, 25], a few studies have indicated that
smoking increases the risk of metabolic syndrome and
abdominal obesity through various mechanisms [26–28].
Smoking has been associated with higher body weight
and metabolic disorders [29]. In addition, smoking
cessation may improve metabolic parameters [26].
Phenomena linking smoking with metabolic syndrome
are therefore complex.
The main objective of this study was to investigate the
potential association of metabolic syndrome with male
idiopathic infertility given smoking status.
Materials and methods
Patients
The data of this study concerned infertile (n = 96) and
fertile (n = 100) men younger than 45 years of age who
were recruited in the ALIFERT case-control study
between September 2009 and December 2013 [30]. The
ALIFERT study was designed to assess the association
between lifestyle factors and idiopathic infertility in
couples (National biomedical research ID no. P071224;
ethics committee approval (‘Comité de Protection des
Personnes’) ID no. AOM 2009-A00256–51; NEudra CT
ID no. 08180; clinicaltrials.gov ID no. NCT01093378).
Idiopathic or unexplained infertility may be defined by
a lack of diagnosis made in couples who failed to con-
ceived after one or two years of unprotected sexual
intercourse [31]. It may impact 30 to 40% of infertile
couples [32]. Standard investigation protocol does not
provide a diagnosis to explain the infertility. In men,
semen analysis is usually performed. It is important to
study idiopathic infertility, indeed: even if no cause is
clearly identified, the environment and lifestyle could
explain it. A better understanding of the origin of the
disorder should help in managing infertile couples.
The study group consisted of infertile male partners of
couples attending four infertility centres in France, as
follows: the Jean Verdier Hospital assisted reproductive
Technology (ART) centre, Bondy; the Cochin Hospital
ART centre, Paris; the Hôpital Nord ART centre, Saint
Etienne; and the Polyclinique de Navarre ART centre,
Pau. Study participants were recruited after an initial
infertility check-up. Semen analysis for conventional
parameters and a semen culture were performed.
Medical examination was performed if necessary and
medical history was reported. Subject eligibility criteria
were (1) primary idiopathic infertility lasting longer than
12months; (2) age younger than 45 years; (3) no severe
oligozoospermia (< 5 million/mL); (4) no alterations of
the male reproductive organs such as undescended
testis, varicocele, or infection; (5) no female factors of
infertility; (6) a female partner age of younger than 38
years; and (7) the provision of written informed consent.
The control group consisted of fertile male volunteers
recruited from the general healthy population in the
areas of the participating centres. Inclusion criteria for
this group were (1) a spontaneously conceived child
under two years of age, (2) time to pregnancy of less
than 12months, (3) age younger than 45 years, (4) a
female partner age of younger than 38 years, and (5) the
provision of written informed consent. Members of the
control group did not undergo clinical examination or
semen parameter analysis before inclusion; however,
they were asked about their medical history.
All participants were Caucasians. Infertile and fertile
males with current known or previous metabolic or
digestive disease were not included.
Assessments
All study and control subjects were assessed by the same
trained investigator using the same calibrated devices.
Anthropometric assessments
Height, weight (Tanita BC-420MA analyser), and waist
circumference at the narrowest point between the lower
border of the ribs and the iliac crest were evaluated.
Blood samples and analyses
Blood samples were collected after a 12-h fasting period.
HDL cholesterol, low-density lipoprotein (LDL) choles-
terol, triglycerides, and glucose concentrations were
instantly measured by standardized methods after centri-
fugation in the hospitals’ biology laboratories.
Blood pressure assessment
Systolic and diastolic blood pressures were measured
using a sphygmomanometer cuff around the patient’s
arm after five minutes of bed rest in a supine position.
The systolic and diastolic blood pressure measurements
were the respective means of their right and left values.
Metabolic syndrome definition
Metabolic syndrome was diagnosed in the presence of at
least three of the following criteria: waist circumference
of more than 92 cm, triglycerides of 150 mg/dL / 1.7
mmol/L or more, HDL cholesterol of less than 40mg/dL
/ 1.0 mmol/L, fasting glucose of 100 mg/dL / 5.6 mmol/L
or more, and arterial blood pressure of 130/85 mmHg or
higher [12].
Smoking status
Patients reported the number of cigarettes smoked per
day and were categorized as a smoker if they smoked
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one or more cigarettes per day and as a nonsmoker if
they did not smoke at all. Exhaled carbon monoxide
(CO) was measured in parts per million (ppm) as a sup-
portive indicator with the underlying assumption that
exhaled carbon monoxide (CO) in smokers [33] is higher
than that in nonsmokers. Exhaled CO measurement was
performed by having subjects exhale completely and
then inhale fully in open air, holding their breath for 10
s, and then exhaling completely into a portable CO
monitor (Tabataba analyser; FIM Medical, Villeurbanne,
France) [33].
Statistical analyses
Data were summarized using means and standard devia-
tions. The following test plan was applied: (1) differences
between infertile and fertile males (t-test), (2) association
between smoking and metabolic syndrome (Fisher’s
exact test), and (3) association between fertility as a
dependent variable and both metabolic syndrome and
smoking as independent variables (logistic regression).
Bonferroni correction was applied to cap overall type I
error to 5% when comparing fertility, metabolic syn-
drome, and smoking, respectively, between the two
groups, thus resulting in a type I error of 1.7% per test.
Results
Population description
No statistical differences were found between infertile
and fertile males in term of age, total cholesterol, LDL
cholesterol, and triglyceride levels. Also, blood pressures
were not significantly different.
However, significant differences did include a higher
BMI in the infertile group versus the control group
[25.9 kg/m2, 95% confidence interval (CI): 25.0–26.7 vs.
23.9, 95% CI: 23.4–24.5; p = 0.00020] as well as a higher
waist circumference (91.5 cm, 95% CI: 89.3–93.8 vs.
86.1, 95% CI: 84.7–87.6; p < 0.0001), a higher fasting
blood glucose (5.0 mmol/L, 95% CI: 4.8–5.1 vs. 4.3, 95%
CI: 4.1–4.5; p < 0.0001), and a lower HDL cholesterol
levels (1.25 mmol/L, 95% CI: 1.18–1.33 vs. 1.38 mmol/L,
95% CI: 1.32–1.44; p < 0.008) (Table 1).
Metabolic syndrome and smoking
Both metabolic syndrome and smoking were found to be
more frequent in infertile than in fertile males (Table 2),
as follows: metabolic syndrome [17/95 (17.9, 95% CI:
10.8–27.1%) vs. 6/99 (6.1, 95% CI: 2.3–12.7%); Fisher’s
exact test p = 0.014] and smoking [27/94 (28.7, 95% CI:
19.9–39.0%) vs. 14/99 (14.1, 95% CI: 8.0–22.6%); Fisher’s
exact test p = 0.014]. Smoking status was not significantly
different between males with vs. without metabolic
syndrome [7/22 (31.8%, 95 CI: 13.9–54.9%) vs. 34/170 (20,
95% CI: 14.3–26.8%); Fisher’s exact test p = 0.27].
Logistic regression confirmed the absence of an inter-
action between metabolic syndrome and smoking.
Exhaled CO was significantly higher in smokers (9.2
ppm, 95% CI: 7.2–11.1) than in nonsmokers (3.4 ppm,
95% CI: 3.1–3.7; p < 0.0001).
Discussion
The strengths of the present study are: (1) comparable
infertile and fertile control groups, with respect to most
variables other than the study variables; (2) the availabil-
ity of data in the fertile control group, and (3) assess-
ments by the same trained investigator using the same
calibrated devices so as to minimize observation bias. A
weakness is the fact that the study sample was identified
through a demand for medical assistance, whereas the
control population was not, thus causing potential
participation bias.
Another limitation was the self-reporting of tobacco
consumption, which may be underestimated by some
men. The assessment of exhaled CO was intended to
support self-reporting, but exhaled CO can be influ-
enced by passive smoking and prolonged exposure to a
polluted environment [34] so that the level of exhaled
Table 1 Comparison of anthropometric, metabolic parameters and exhaled CO between subfertile and fertile men
Subertile (n = 96) Fertile (n = 100) p
Age 33.3[32.2, 34.3] 34.4 [33.7, 35.1] NS
BMI (Kg.m-2) 25.9 [25.0, 26.7] 23.9 [23.4, 24.5] 0.0002
Waist circumference (cm) 91.5 [89.3, 93.8] 86.1 [84.7, 87.6] 0.0001
Fasting blood glucose (mmol/l) 5.0 [4.8, 5.1] 4.3 [4.1, 4.5] < 0.0001
Total cholesterol (mmol/l) 5.2 [5.01, 5.40] 5.2 [5.02, 5.38] NS
HDL cholesterol (mmol/l) 1.25 [1.18, 1.33] 1.38 [1.32, 1.44] < 0.008
LDL cholesterol (mmol/l) 3.28 [3.09, 3.47] 3.24 [3.06, 3.41] NS
Triglycerides (mmol/l) 1.42 [1.23, 1.62] 1.20 [1.06, 1.33] NS
Systolic blood pressure (mmHg) 126 [124, 129] 126 [124, 128] NS
Diastolic blood pressure (mmHg) 81 [79, 83] 80 [79, 82] NS
Data reported as mean and 95% CI (confidence interval). BMI (body mass index), HDL (high density lipoprotein), LDL (low density lipoprotein)
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CO does not necessarily accurately reflect the amount of
smoking done by a subject.
Previous studies have separately analysed the association
between semen parameters and abdominal obesity or
metabolic syndrome on the one hand and between semen
parameters and smoking on the other. Many of these
studies suggested a negative impact of abdominal obesity
or metabolic syndrome on semen parameters [3, 13, 14].
However, they did not assess male fertility. Other studies
have highlighted the negative impact of smoking on
semen parameters [21].
The mechanisms involved in these phenomena are com-
plex and multifactorial. Overweightness and obesity have
been known for a long time to have a negative impact on
conventional and nonconventional semen parameters
[35]. Hormonal disorders, systemic inflammation, oxida-
tive stress, and scrotal temperature increase related to
obesity are involved in the observed effects. However, it is
important to consider the comorbidities associated with
obesity, which can also play a critical role. For example,
diabetes mellitus may alter semen parameters and male
fertility through various mechanisms [36]. There is more
evidence that obesity, metabolic disorders, and diabetes
mellitus decrease serum testosterone levels. This action
may be associated with a defect in Leydig cells [36].
Furthermore, obesity and metabolic disorders are associ-
ated with a decrease in androgen production and an
increase in aromatase activity as linked to excess adipose
tissue. Insulin resistance is responsible for a decrease in
sex hormone–binding globulin levels. The consequences
are a decrease in plasma testosterone levels and an
increase in estradiolemia. Feedback from the hypothal-
amic–pituitary–gonadal axis is therefore disrupted, lead-
ing to hypogonadism. The functions of Sertoli cells are
therefore impacted and sperm production is altered.
The originality of the present case-control study was to
jointly compare anthropometric and metabolic parameters
and smoking in the male partners of idiopathic infertile
couples and fertile couples, respectively. The results of this
study suggest metabolic syndrome and smoking to be
independent risk factors for idiopathic infertility.
Few studies so far have assessed the effect of smoking
cessation on semen parameters, hormonal status [37],
male fertility, and changes in sexual dysfunction [38, 39].
Nicotine may have a direct negative effect on sperm
quality [40], and smoking is understood to alter sperm
DNA integrity and induce sperm apoptosis [41].
The results of these previous studies support the need
to encourage smoking cessation among infertile men.
However, it is important to anticipate weight gain after
tobacco cessation [42], given that weight gain can be
associated with metabolic disorders and overweightness
and obesity, which are known to impact male fertility.
While previously published studies found an increased
risk of metabolic syndrome in active smokers, the
current study was not able to find a significant effect, al-
though we found nonsignificantly identified higher rates
of metabolic syndrome in smokers [26, 27].
It is widely recognized that nutritional management
and increased physical activity can improve cardiovascu-
lar comorbidities associated with the metabolic
syndrome [43], but to our knowledge no data are avail-
able about the impact of lifestyle interventions on repro-
ductive functions in the case of metabolic disorders or
metabolic syndrome.
Several studies have shown an improvement in the
hormonal balance and erectile function of obese patients
after weight loss [44–46]. However, the impact of weight
loss on sperm parameters has only been investigated in a
limited fashion to date. An improvement in sperm pa-
rameters after weight loss has been reported in two
studies [45, 47]. Additionally, it has been previously
noted in six men with abdominal obesity that abdominal
fat loss led to an improvement of sperm DNA integ-
rity linked to an oxidative stress decrease and an anti-
oxidant protection increase in seminal plasma. All
female partners became pregnant following the
lifestyle intervention [4].
The results of our study suggest that personal and
multifaceted coaching should be proposed to deal jointly
with smoking and metabolic disorders through nutri-
tional improvement, physical activity, and treatments for
high blood pressure and diabetes mellitus. The comple-
tion of further prospective interventional randomized
controlled trials would be relevant to quantify the bene-
fit of such an approach.
For greater efficiency, young men should be informed
about the effects of metabolic syndrome and smoking
on fertility as soon as possible. They should strive to
improve their lifestyle before they face difficulties with
conceiving a child.
Others environmental effects that were not assessed in
this study are of importance and may challenge male fer-
tility. Poor lifestyle can also be associated with excessive
alcohol consumption, and this can have repercussions on
male fertility [48]. Furthermore, men with metabolic
disorders and, in particular, dyslipidaemia, may be treated
with statins that may reduce testosterone levels and inter-
fere with reproductive functions [49]. Finally, exposure to
other environmental toxins such as pollution or mobile
phone radiation [50] may be confounding factors.
Table 2 Proportion of men with metabolic syndrome and
smokers between the groups of subfertile and fertile men
Subertile (n = 96) Fertile (n = 99) p
Metabolic syndrome (%, CI) 17.9 [10.0, 25.7] 6.1 [1.3, 10.8] 0.0115
Smokers (%, CI) 28.7 [19.4,38.0] 14.1 [7.2, 21.1] 0.014
CI (confidence interval)
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Conclusion
The present study reports that infertile men demonstrate
a poorer health condition as compared with fertile men
and are more often smokers. Metabolic syndrome and
tobacco in men appear as significant and independent
risks factors for idiopathic infertility. Health care profes-
sionals should be aware of this phenomenon and risks
factors should systematically be checked at the begin-
ning of medical care, considering that adverse conse-
quences may be reversible or even preventable.
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